Healthcare Services

Neurotechnology Market Outlook: Growth and Forecast Highlights 2030

February 27, 2026April 15, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the neurotechnology market from 2026–2035 with trusted insights from The Business Research Company

What level of growth is expected in the Neurotechnology Market between 2026 and 2030?

The neurotechnology market size has experienced significant expansion recently. This market is projected to expand from $17.34 billion in 2025 to $19.84 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 14.4%. Historically, this expansion has been driven by several key factors, including breakthroughs in medical imaging technologies, the early uptake of neurostimulation therapies, an increase in clinical research within neurology, the rising occurrence of neurological disorders, and advancements in implantable device technology.

The neurotechnology market is projected to experience substantial expansion in the coming years, set to reach $33.64 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 14.1%. This growth during the forecast period is primarily driven by increasing investment in brain-computer interfaces, a rising demand for personalized neurological treatments, the expanding application of AI-driven diagnostics, greater adoption of home-based neurotechnology, and the advancement of minimally invasive neurotherapies. Key trends anticipated in the same period involve the broadening of brain-computer interface solutions, increased uptake of non-invasive neurostimulation devices, enhanced integration of neuroimaging within clinical diagnostics, a growing need for cognitive rehabilitation technologies, and improvements in neurological implant materials.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9840&type=smp

Which Drivers Are Expected To Impact The Neurotechnology Market During The Forecast Period?

The rising occurrence of neurological conditions is anticipated to boost the expansion of the neurotechnology market going forward. A neurological condition refers to any ailment or illness impacting the brain, with common examples including Alzheimer’s disease, Parkinson’s disease, epilepsy, and migraine. Neurotechnology finds application in diagnosing and addressing neurological disorders through diverse methods such as brain imaging, neurostimulation, neurofeedback, and brain-computer interfaces. As an illustration, data from October 2023 provided by the World Federation of Neurology, a UK-based charity, indicates an escalating global health burden: neurological disorders are now the second-leading cause of death and the primary cause of disability across the globe. It also noted that more than 40 percent of the worldwide population was affected in 2023, and the count of people living with brain disease is projected to nearly double by 2050. Consequently, the expanding occurrence of neurological conditions is propelling the growth of the neurotechnology market going forward.

Which Segments Are Driving Activity In The Neurotechnology Market?

The neurotechnology market covered in this report is segmented –

1) By Conditions: Cognitive Disorders, Pain Treatment, Urinary And Fecal Incontinence, Epilepsy, Parkinson’s Disease, Hearing Conditions, Sleep Disorder, Depression, Other Conditions

2) By Type: Imaging Modalities, Neurostimulation, Cranial Surface Measurement, Neurological Implants, Other Types

3) By End Use: Ambulatory Surgical Centers, Hospitals, Homecare Facilities, Other End Uses

Subsegments:

1) By Cognitive Disorders: Alzheimer’s Disease, Attention Deficit Hyperactivity Disorder (ADHD), Dementia

2) By Pain Treatment: Chronic Pain, Neuropathic Pain, Acute Pain

3) By Urinary And Fecal Incontinence: Overactive Bladder, Neurogenic Bladder, Fecal Incontinence Management

4) By Epilepsy: Drug-Resistant Epilepsy, Seizure Management Devices

5) By Parkinson’s Disease: Motor Symptoms Management, Non-Motor Symptoms Management

6) By Hearing Conditions: Tinnitus, Hearing Loss Solutions

7) By Sleep Disorder: Insomnia, Sleep Apnea, Restless Legs Syndrome

8) By Depression: Major Depressive Disorder, Treatment-Resistant Depression

9) By Other Conditions: Anxiety Disorders, Autism Spectrum Disorder, Traumatic Brain Injury (TBI)

Which Innovation Trends Are Advancing Developments Within The Neurotechnology Market?

Leading companies in the neurotechnology market are concentrating on developing sophisticated therapeutic options, such as the endovascular brain-computer interface (BCI), to improve cognitive function and restore mobility for individuals with neurological impairments. This endovascular brain-computer interface (BCI) facilitates direct neural access via blood vessels, thereby offering enhanced interaction and treatment possibilities for patients with neurological conditions. For instance, in April 2024, Synchron, a Sweden-based software company focused on creating advanced synchronization technologies for seamless data integration and management, launched a Patient Registry for its Stentrode Brain Computer Interface. The Synchron Stentrode BCI technology is engineered to interpret brain signals and restore motor intent, enabling individuals with limited mobility to operate digital devices without physical interaction. Implanted through a non-invasive endovascular procedure, it wirelessly transmits motor intentions from the brain, allowing severely paralyzed patients to regain a degree of independence. This pioneering technology signifies a substantial advancement in assistive solutions, enhancing daily activities such as communication and access to essential services.

Which Major Industry Participants Are Leading The Neurotechnology Market Growth?

Major companies operating in the neurotechnology market are General Electric, Medtronic PLC, Koninklijke Philips N.V., Shimadzu Corporation, Elekta AB, Natus Medical Incorporated, Abbott, Boston Scientific Corporation, Nihon Kohden Corporation, LivaNova PLC, Siemens Healthcare Private Limited, Hitachi Medical Corporation, Cochlear Limited, NeuroPace Inc., NeuroSigma Inc., NeuroMetrix Inc., NeuroSky Inc., NeuroVigil Inc., Neurotech Pharmaceuticals Inc., Neuralink, Synchron Inc., Blackrock Neurotech, Neuronetics Inc., Neurable Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/neurotechnology-global-market-report

Which Geographic Areas Are Emerging As Strong Markets For The Neurotechnology Market?

North America was the largest region in the neurotechnology market in 2025. Europe is expected to be the fastest-growing region in the neurotechnology market report during the forecast period. The regions covered in the neurotechnology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Neurotechnology Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=9840&type=smp

Browse Through More Reports Similar to the Global Neurotechnology Market 2026, By The Business Research Company

Neuromodulation Market Report 2026

https://www.thebusinessresearchcompany.com/report/neuromodulation-global-market-report

Neuroscience Market Report 2026

https://www.thebusinessresearchcompany.com/report/neuroscience-global-market-report

Neuroprosthetics Market Report 2026

https://www.thebusinessresearchcompany.com/report/neuroprosthetics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795